These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2107935

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Current trends in medical therapy of chronic peripheral obliterating arteriopathies].
    Peruzzi G, Tallarida G, Baldoni F, Raimondi G, Grimaldi I, Sangiorgi M.
    Clin Ter; 1985 Jul 15; 114(1):3-26. PubMed ID: 2864161
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):41. PubMed ID: 14974333
    [No Abstract] [Full Text] [Related]

  • 6. [Improvement of walking disability and conservative treatment. Guiding principles for drug treatment of chronic arterial occlusive disease (stage I and IIb)].
    Heinrich F.
    Fortschr Med; 1984 Sep 27; 102(36):74-5. PubMed ID: 6489898
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Emerging drugs in peripheral arterial disease.
    Tulsyan N, Ouriel K, Kashyap VS.
    Expert Opin Emerg Drugs; 2006 Mar 27; 11(1):75-90. PubMed ID: 16503827
    [Abstract] [Full Text] [Related]

  • 9. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
    Offerhaus L.
    Ned Tijdschr Geneeskd; 1981 Feb 07; 125(6):228-34. PubMed ID: 7207673
    [No Abstract] [Full Text] [Related]

  • 10. [Effects of vaso-active medications on cerebral circulation].
    Pratesi F, Corsi C, Tesi M, Spinelli P, Brunetti S, Caramelli L.
    Cah Coll Med Hop Paris; 1968 Jul 07; 9(8):711-27. PubMed ID: 5683896
    [No Abstract] [Full Text] [Related]

  • 11. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May 23; 144(21):54. PubMed ID: 12134429
    [No Abstract] [Full Text] [Related]

  • 12. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases].
    De Gregorio G, Restivo S.
    Clin Ter; 1982 Dec 15; 103(5):501-7. PubMed ID: 7160142
    [No Abstract] [Full Text] [Related]

  • 13. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK.
    Munch Med Wochenschr; 1973 Oct 05; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract] [Full Text] [Related]

  • 14. [Medical treatment of peripheral occlusive arteriopathies. Possibilities, principles and basis].
    Heidrich H.
    Minerva Med; 1979 Oct 31; 70(47):3255-63. PubMed ID: 390422
    [No Abstract] [Full Text] [Related]

  • 15. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
    Forconi S, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Ralli L, Guerrini M, Di Perri T.
    J Int Med Res; 1984 Oct 31; 12(3):188-92. PubMed ID: 6734922
    [No Abstract] [Full Text] [Related]

  • 16. Vasodilators: minoxidil and drugs used in peripheral vascular and cerebral disorders.
    Lowe GD.
    Br Med J (Clin Res Ed); 1983 Apr 16; 286(6373):1262-4. PubMed ID: 6404416
    [No Abstract] [Full Text] [Related]

  • 17. Medical treatment of peripheral vascular disease: good or bad?
    Duprez D, Clement DL.
    Eur Heart J; 1992 Feb 16; 13(2):149-51. PubMed ID: 1555609
    [Abstract] [Full Text] [Related]

  • 18. [Medical therapy of acute peripheral ischemia].
    Basellini A, Martelli E, Losa S.
    Minerva Med; 1985 Mar 17; 76(11):501-3. PubMed ID: 3982684
    [No Abstract] [Full Text] [Related]

  • 19. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G, Balzer K, Bisler H, Klüken N, Mahfoud Y, Müller-Wiefel H, Unkel B, Ziegler W.
    Dtsch Med Wochenschr; 1982 Dec 24; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract] [Full Text] [Related]

  • 20. [Physiopathology and therapy of obliterating arteriopathies].
    Schettler G, Mörl H.
    Clin Ter; 1979 Jan 15; 88(1):3-19. PubMed ID: 436376
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.